DeLuca Richard R. 4
4 · Merck & Co., Inc. · Filed May 6, 2024
Insider Transaction Report
Form 4
DeLuca Richard R.
EVP&Pres, Merck Animal Heallth
Transactions
- Exercise/Conversion
Common Stock
2024-05-04$127.51/sh+27,126$3,458,836→ 163,719.559 total - Tax Payment
Common Stock
2024-05-04$127.51/sh−13,360$1,703,534→ 150,359.559 total - Exercise/Conversion
Restricted Stock Unit
2024-05-04−27,126→ 0 totalFrom: 2024-05-04Exp: 2024-05-04→ Common Stock (27,126 underlying)
Holdings
- 1,236.602(indirect: By 401(k))
Common Stock - 401(k) Plan
Footnotes (4)
- [F1]Holdings include shares acquired in dividend reinvestment transactions.
- [F2]Includes shares acquired and dividends earned through April 5, 2024 in the Merck U.S. Savings Plan, a 401(k) plan.
- [F3]Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.
- [F4]These restricted stock units vested and were distributed as shares of Merck & Co., Inc. common stock in one installment on 5/4/2024.